Questions — and for some, outrage — intensified over several of United States President-elect Donald Trump's Cabinet picks on ...

In Q1 and Q2 of calendar 2025, Medicenna anticipates achieving several milestones in the MDNA11 program. These include completing monotherapy expansion and combination dose-escalation enrollment, ...

Pharmaceutical company QOL Medical and its CEO, Frederick Cooper, have agreed to pay $47 million to settle allegations that they violated the False Claims Act by offering kickbacks to healthcare ...

Leaders in the scientific community, biopharma world, and veterans of the federal health agencies provide wide-ranging reactions to the news that Robert F. Kennedy Jr. will be nominated as the ...